BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 31843751)

  • 21. In vivo evaluation of a radiogallium-labeled bifunctional radiopharmaceutical, Ga-DOTA-MN2, for hypoxic tumor imaging.
    Sano K; Okada M; Hisada H; Shimokawa K; Saji H; Maeda M; Mukai T
    Biol Pharm Bull; 2013; 36(4):602-8. PubMed ID: 23546294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A gallium-labeled DOTA-alpha-melanocyte- stimulating hormone analog for PET imaging of melanoma metastases.
    Froidevaux S; Calame-Christe M; Schuhmacher J; Tanner H; Saffrich R; Henze M; Eberle AN
    J Nucl Med; 2004 Jan; 45(1):116-23. PubMed ID: 14734683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer.
    Benešová M; Schäfer M; Bauder-Wüst U; Afshar-Oromieh A; Kratochwil C; Mier W; Haberkorn U; Kopka K; Eder M
    J Nucl Med; 2015 Jun; 56(6):914-20. PubMed ID: 25883127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PET/CT Imaging of NSCLC with a α
    Flechsig P; Lindner T; Loktev A; Roesch S; Mier W; Sauter M; Meister M; Herold-Mende C; Haberkorn U; Altmann A
    Mol Imaging Biol; 2019 Oct; 21(5):973-983. PubMed ID: 30671741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation,
    Barta P; Kamaraj R; Kucharova M; Novy Z; Petrik M; Bendova K; Hajduch M; Pavek P; Trejtnar F
    Bioconjug Chem; 2022 Oct; 33(10):1825-1836. PubMed ID: 36197842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiosynthesis and preclinical evaluation of [
    Moisio O; Palani S; Virta J; Elo P; Liljenbäck H; Tolvanen T; Käkelä M; Miner MG; Herre EA; Marjamäki P; Örd T; Heinäniemi M; Kaikkonen MU; Zhang F; Srinivasarao M; Knuuti J; Low PS; Saraste A; Li XG; Roivainen A
    Sci Rep; 2020 Aug; 10(1):13593. PubMed ID: 32788595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CMKLR1-targeting peptide tracers for PET/MR imaging of breast cancer.
    Erdmann S; Niederstadt L; Koziolek EJ; Gómez JDC; Prasad S; Wagener A; von Hacht JL; Reinicke S; Exner S; Bandholtz S; Beindorff N; Brenner W; Grötzinger C
    Theranostics; 2019; 9(22):6719-6733. PubMed ID: 31588246
    [No Abstract]   [Full Text] [Related]  

  • 28. Imaging of human epidermal growth factor receptor type 2 expression with 18F-labeled affibody molecule ZHER2:2395 in a mouse model for ovarian cancer.
    Heskamp S; Laverman P; Rosik D; Boschetti F; van der Graaf WT; Oyen WJ; van Laarhoven HW; Tolmachev V; Boerman OC
    J Nucl Med; 2012 Jan; 53(1):146-53. PubMed ID: 22173842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preclinical Comparative Study of (68)Ga-Labeled DOTA, NOTA, and HBED-CC Chelated Radiotracers for Targeting PSMA.
    Ray Banerjee S; Chen Z; Pullambhatla M; Lisok A; Chen J; Mease RC; Pomper MG
    Bioconjug Chem; 2016 Jun; 27(6):1447-55. PubMed ID: 27076393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting and imaging of HER2 overexpression tumor with a new peptide-based
    Biabani Ardakani J; Akhlaghi M; Nikkholgh B; Hosseinimehr SJ
    Bioorg Chem; 2021 Jan; 106():104474. PubMed ID: 33246602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The glucose-dependent insulinotropic polypeptide receptor: a novel target for neuroendocrine tumor imaging—first preclinical studies.
    Gourni E; Waser B; Clerc P; Fourmy D; Reubi JC; Maecke HR
    J Nucl Med; 2014 Jun; 55(6):976-82. PubMed ID: 24744444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Use of PET Imaging for Prognostic Integrin α
    Huang CW; Hsieh WC; Hsu ST; Lin YW; Chung YH; Chang WC; Chiu H; Lin YH; Wu CP; Yen TC; Huang FT
    Theranostics; 2017; 7(16):4013-4028. PubMed ID: 29109795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting of MMP2 activity in malignant tumors with a 68Ga-labeled gelatinase inhibitor cyclic peptide.
    Liu Q; Pan D; Cheng C; Zhang A; Ma C; Wang L; Zhang D; Liu H; Jiang H; Wang T; Xu Y; Yang R; Chen F; Yang M; Zuo C
    Nucl Med Biol; 2015 Dec; 42(12):939-44. PubMed ID: 26344861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alpha v beta 3 integrin-targeting of intraperitoneally growing tumors with a radiolabeled RGD peptide.
    Dijkgraaf I; Kruijtzer JA; Frielink C; Corstens FH; Oyen WJ; Liskamp RM; Boerman OC
    Int J Cancer; 2007 Feb; 120(3):605-10. PubMed ID: 17096340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Novel Small Cyclic Peptide-Based
    Liu H; Hu M; Deng J; Zhao Y; Peng D; Feng Y; Wang L; Chen Y; Qiu L
    Mol Pharm; 2022 Jan; 19(1):138-147. PubMed ID: 34910492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of Intestinal Inflammation by Vascular Adhesion Protein-1-Targeted [
    Bhowmik AA; Heikkilä TRH; Polari L; Virta J; Liljenbäck H; Moisio O; Li XG; Viitanen R; Jalkanen S; Koffert J; Toivola DM; Roivainen A
    Mol Imaging Biol; 2024 Apr; 26(2):322-333. PubMed ID: 38110791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers.
    Persson M; Madsen J; Østergaard S; Ploug M; Kjaer A
    Nucl Med Biol; 2012 May; 39(4):560-9. PubMed ID: 22172391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the RGD Motif-Containing α
    Roesch S; Lindner T; Sauter M; Loktev A; Flechsig P; Müller M; Mier W; Warta R; Dyckhoff G; Herold-Mende C; Haberkorn U; Altmann A
    J Nucl Med; 2018 Nov; 59(11):1679-1685. PubMed ID: 29674419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pretargeted immuno-positron emission tomography imaging of carcinoembryonic antigen-expressing tumors with a bispecific antibody and a 68Ga- and 18F-labeled hapten peptide in mice with human tumor xenografts.
    Schoffelen R; Sharkey RM; Goldenberg DM; Franssen G; McBride WJ; Rossi EA; Chang CH; Laverman P; Disselhorst JA; Eek A; van der Graaf WT; Oyen WJ; Boerman OC
    Mol Cancer Ther; 2010 Apr; 9(4):1019-27. PubMed ID: 20354120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiosynthesis, Biological Evaluation, and Preclinical Study of a
    Pirooznia N; Abdi K; Beiki D; Emami F; Arab SS; Sabzevari O; Pakdin-Parizi Z; Geramifar P
    Contrast Media Mol Imaging; 2020; 2020():8421657. PubMed ID: 32292304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.